Combination therapy with ixekizumab and tirzepatide bested monotherapy with ixekizumab alone in both psoriatic arthritis and ...

New weight-loss drugs in the works will offer more choices beyond GLP-1 options Wegovy and Zepbound. What to know about ...

What happens with Eli Lilly's GLP-1 shot now that Novo Nordisk has come out with a GLP-1 pill?

The choice isn't that hard.

The past couple of years have been challenging for the company. But this could be the beginning of a new chapter.

Novo Nordisk's FDA-approved Wegovy pill marks a new era in obesity treatment, expanding access to GLP-1 therapy through ...

The weight loss drug Wegovy is now available as a tablet in more than 70,000 U.S. pharmacies as well as select telehealth ...

In an open-label phase 3b trial, the co-administration of Lilly’s IL-17A antagonist Taltz (ixekizumab) and dual GIP/GLP-1 ...

RANTOUL, Ill. (WCIA) — With a new year comes a new set of resolutions and options in the weight loss game. Injectable GLP-1 ...

The TOGETHER-PsA study shows that combining ixekizumab with tirzepatide leads to significantly better psoriatic arthritis ...

Eli Lily has announced positive topline results from the novel TOGETHER-PsA open-label Phase IIIb trial evaluating ...

Wegovy pill introduction in the U.S. may serve as the turning point that transforms a beleaguered GLP‑1 leader into a viable ...